Glaucoma 360

Dry eye gains importance in glaucoma careNew treatments and greater awareness are making dry eye an even more important part of glaucoma care, according to Richard Lewis, MD, of Sacramento Eye Consultants.
Cannabis remains problematic for glaucoma
Cannabis remains problematic for glaucomaDespite the legalization of marijuana by several state governments, physicians should not recommend smoking it as a treatment for glaucoma, said Sunita Radhakrishnan, MD. “It has been approved by public opinion rather than regulatory process,” she said.
MACRA changes deemed likely to survive new administrationOphthalmologists are likely to continue grappling with changes brought about by the Medicare Access and CHIPS (Children’s Health Insurance Program) Reauthorization Act (MACRA) under the administration of President Donald J. Trump, according to Ruth D. Williams, MD.
How OCT innovations are changing glaucoma careOptical coherence tomography (OCT) is swiftly improving the diagnosis of glaucoma, according to Joel S. Schuman, MD, who helped invent the technology.
FDA works to bring patient perspective to MIGS
New measure of cell metabolism may speed progress of therapies
Rochester University researcher awarded 2017 Shaffer PrizeFor his research efforts to better understand the molecular pathways that are responsible for axonal degeneration in glaucoma, Richard Libby, PhD, was awarded the 2017 Shaffer Prize for Research during Thursday night’s Glaucoma 360 annual Gala.
Glaucoma 360 expands its ‘horizons’ with new program, sessionsOver the years, Glaucoma 360 has brought the concept of innovation in glaucoma to the forefront. This year’s meeting will surpass the Glaucoma Research Foundation’s (GRF) own “Horizons” by adding a few more “degrees” to its 360-degree concept.
Dr. de Juan receives Catalyst Award; opera singer Márquez gets Visionary AwardA renowned ophthalmologist and an accomplished opera singer were the highlight of Thursday night’s Glaucoma 360 annual Gala, when the two were presented with the Glaucoma Research Foundation’s (GRF) highest honors—The Catalyst Award and Visionary Award.
Glaucoma 360 approaches disease from every angleResearch. Industry. Philanthropy. These three facets—each with a unique purpose—will come together for the 2017 installment of the annual Glaucoma Research Foundation (GRF) Glaucoma 360 meeting. The three-day event will occur Feb. 2 to 4, 2016.